ClinicalTrials.Veeva

Menu
C

Chulalongkorn Hospital | Faculty of Medicine, Infectious Disease Unit

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Cyclofem
BI 1819479
purite
Libido
Xalatan
Iron
Velpatasvir
Ribavirin
SH T00658ID
Sofosbuvir

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 19 total trials

A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

This study is open to adults 40 years or older with idiopathic pulmonary fibrosis (IPF). People can join the study if they are not on any treatment f...

Enrolling
Idiopathic Pulmonary Fibrosis
Drug: Placebo matching BI 1819479
Drug: BI 1819479

Adults 40 years of age and older with idiopathic pulmonary fibrosis (IPF) or 18 years and older with progressive pulmonary fibrosis (PPF) can partici...

Enrolling
Progressive Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Drug: BI 1839100
Drug: Placebo

Trial sponsors

C
Boehringer Ingelheim logo
Bayer logo
Gilead Sciences logo
H
M
Smith & Nephew logo
Viatris logo
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems